研究单位:[1] Eli Lilly and Company[2]Peking University Peoples Hospital[3]Shantou University Medical College No.2 Affiliated Hospital [4]Wu Han Tongji Hospital
The purpose of this study is to compare long-acting basal insulin analog LY2963016 to Lantus® in combination with mealtime insulin lispro in adult Chinese participants with Type 1 Diabetes Mellitus (T1DM).